David Domzalski

Chief Executive Officer at Foamix Pharmaceuticals Ltd.

David Domzalski

David Domzalski

Chief Executive Officer at Foamix Pharmaceuticals Ltd.

Overview
Career Highlights

Foamix Pharmaceuticals, Inc.
Foamix Pharmaceuticals Ltd.

RelSci Relationships

106

Number of Boards

2

Birthday

1967

Age

52

Relationships
RelSci Relationships are individuals David Domzalski likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Counsel & Chief Legal Officer at Foamix Pharmaceuticals Ltd.

Relationship likelihood: Strong

Chief Commercial Officer at Foamix Pharmaceuticals Ltd.

Relationship likelihood: Strong

Co-Founder at Foamix Pharmaceuticals Ltd.

Relationship likelihood: Strong

Chief Scientific Officer at Foamix Pharmaceuticals Ltd.

Relationship likelihood: Strong

Chief Executive Officer at FuturaGene Ltd.

Relationship likelihood: Strong

Former Innovation Advisor at Foamix Pharmaceuticals Ltd.

Relationship likelihood: Strong

President & Chief Executive Officer at Seabright Associates, Inc.

Relationship likelihood: Strong

Managing Partner at Alnitak Capital LLC

Relationship likelihood: Strong

Managing Partner at Primary I-Research LLC

Relationship likelihood: Strong

Former Head-Innovative Ventures at Teva Pharmaceutical Industries Ltd.

Relationship likelihood: Strong

Paths to David Domzalski
Potential Connections via
Relationship Science
You
David Domzalski
Chief Executive Officer at Foamix Pharmaceuticals Ltd.
Education

Founded in 1848, Muhlenberg is a highly selective, private, four-year liberal arts college. The College took its present name in 1867 from Henry Melchior Muhlenberg, patriarch of the Lutheran Church in the American Colonies. The College offers 40 majors in the humanities, fine arts, social sciences and natural sciences, in addition to strong pre-professional programs in such areas as pre-health, pre-law, pre-theology, business and education.

Career History
Chief Executive Officer
2014 - Current

Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.

President
2014 - Prior

Foamix Pharmaceuticals, Inc., part of Foamix Pharmaceuticals Ltd., is an American company located in Bridgewater, NJ. The firm manufactures pharmaceutical products. It was founded in 2014.

Vice President-Sales & Marketing
2009 - 2013

Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Domzalski. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Domzalski's profile does not indicate a business or promotional relationship of any kind between RelSci and David Domzalski.